Literature DB >> 16331294

Porcine left atrial and sinoatrial 5-HT(4) receptor-induced responses: fading of the response and influence of development.

Joris H De Maeyer1, Roel Straetemans, Jan A J Schuurkes, Romain A Lefebvre.   

Abstract

1.--In this study, we aimed to characterize in vitro the effects of the benzofuran 5-HT(4) receptor agonists prucalopride, R149402 and R199715 and the indolic agents tegaserod and 5-HT in the atria of young pigs (10-11 weeks) and newborn piglets. 2.--In the paced left atrium of young pigs, only 5-HT results in positive inotropic responses when administered cumulatively (maximal effect relative to isoprenaline=53%, pEC(50)=6.8); however, all agonists showed lusitropic effects. Noncumulative administration results in greater positive inotropic responses for 5-HT and induces moderate positive inotropic responses for the other agonists; these responses fade. 3.--Phosphodiesterase (PDE) enzyme inhibition with 3-isobutyl-1-methylxanthine (IBMX; 20 microM) enhances the responses to cumulatively administered 5-HT (maximal effect=89%, pEC(50)=7.7) and reveals clear positive inotropic effects for prucalopride, tegaserod, R149402 and R199715; fading is abolished. The maximal effect of the benzofurans is less pronounced than that of the indoles. 4.--In the spontaneously beating right atrium of young pigs, all agonists show chronotropic activity when administered cumulatively in the absence of IBMX, without fade. Benzofurans behaved as partial agonists compared to 5-HT (maximal effect=54%, pEC(50)=6.5). 5.--In newborns, the inotropic activity of the agonists in the IBMX-treated left atrium was less pronounced than in the young pig; the same applied for the chronotropic response in the right atrium, except for 5-HT. 6.--In conclusion, the atrial responses to 5-HT(4) receptor activation increase in the first months of life; the inotropic response is regulated by PDEs. Prucalopride, R149402 and R199715 are partial agonists compared to 5-HT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16331294      PMCID: PMC1615862          DOI: 10.1038/sj.bjp.0706497

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  71 in total

1.  Differential functional effects of two 5-HT4 receptor isoforms in adult cardiomyocytes.

Authors:  Liliana Castro; Jeanne Mialet-Perez; Aurélie Guillemeau; Francesca Stillitano; Oliver Zolk; Thomas Eschenhagen; Frank Lezoualc'h; Pascal Bochet; Rodolphe Fischmeister
Journal:  J Mol Cell Cardiol       Date:  2005-08       Impact factor: 5.000

2.  Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure.

Authors:  Eirik Qvigstad; Trond Brattelid; Ivar Sjaastad; Kjetil Wessel Andressen; Kurt A Krobert; Jon Arne Birkeland; Ole M Sejersted; Alberto J Kaumann; Tor Skomedal; Jan-Bjørn Osnes; Finn Olav Levy
Journal:  Cardiovasc Res       Date:  2005-03-01       Impact factor: 10.787

3.  Palmitoylation of the 5-hydroxytryptamine4a receptor regulates receptor phosphorylation, desensitization, and beta-arrestin-mediated endocytosis.

Authors:  Evgeni Ponimaskin; Aline Dumuis; Florence Gaven; Gaël Barthet; Martin Heine; Konstantin Glebov; Diethelm W Richter; Martin Oppermann
Journal:  Mol Pharmacol       Date:  2005-02-02       Impact factor: 4.436

4.  Constitutive dimerization of human serotonin 5-HT4 receptors in living cells.

Authors:  Magali Berthouze; Mohammed Ayoub; Olivier Russo; Lucie Rivail; Sames Sicsic; Rodolphe Fischmeister; Isabelle Berque-Bestel; Ralf Jockers; Frank Lezoualc'h
Journal:  FEBS Lett       Date:  2005-06-06       Impact factor: 4.124

5.  Electrophysiological effects of prucalopride, a novel enterokinetic agent, on isolated atrial myocytes from patients treated with beta-adrenoceptor antagonists.

Authors:  Davide Pau; Antony J Workman; Kathleen A Kane; Andrew C Rankin
Journal:  J Pharmacol Exp Ther       Date:  2005-01-11       Impact factor: 4.030

6.  PKA-mediated phosphorylation of the beta1-adrenergic receptor promotes Gs/Gi switching.

Authors:  Negin P Martin; Erin J Whalen; Musa A Zamah; Kristen L Pierce; Robert J Lefkowitz
Journal:  Cell Signal       Date:  2004-12       Impact factor: 4.315

7.  New sorting nexin (SNX27) and NHERF specifically interact with the 5-HT4a receptor splice variant: roles in receptor targeting.

Authors:  Lara Joubert; Brendon Hanson; Gaël Barthet; Michèle Sebben; Sylvie Claeysen; Wanjin Hong; Philippe Marin; Aline Dumuis; Joël Bockaert
Journal:  J Cell Sci       Date:  2004-10-05       Impact factor: 5.285

8.  Negative feedback exerted by cAMP-dependent protein kinase and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes: an in vivo study using adenovirus-mediated expression of CNG channels.

Authors:  Francesca Rochais; Grégoire Vandecasteele; Florence Lefebvre; Claire Lugnier; Hazel Lum; Jean-Luc Mazet; Dermot M F Cooper; Rodolphe Fischmeister
Journal:  J Biol Chem       Date:  2004-10-01       Impact factor: 5.157

9.  Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure.

Authors:  Trond Brattelid; Eirik Qvigstad; James A Lynham; Peter Molenaar; Halfdan Aass; Odd Geiran; Tor Skomedal; Jan-Bjørn Osnes; Finn Olav Levy; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-07       Impact factor: 3.000

Review 10.  Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes.

Authors:  George S Baillie; Miles D Houslay
Journal:  Curr Opin Cell Biol       Date:  2005-04       Impact factor: 8.382

View more
  12 in total

1.  Study of the regulation of the inotropic response to 5-HT4 receptor activation via phosphodiesterases and its cross-talk with C-type natriuretic peptide in porcine left atrium.

Authors:  S Weninger; J H De Maeyer; R A Lefebvre
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-03-17       Impact factor: 3.000

2.  Fading of 5-HT4 receptor-mediated inotropic responses to 5-hydroxytryptamine is caused by phosphodiesterase activity in porcine atrium.

Authors:  Alberto J Kaumann; Finn Olav Levy
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  Selective desensitization of the 5-HT4 receptor-mediated response in pig atrium but not in stomach.

Authors:  J H De Maeyer; J A J Schuurkes; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2009-01-13       Impact factor: 8.739

4.  Influence of phosphodiesterases and cGMP on cAMP generation and on phosphorylation of phospholamban and troponin I by 5-HT4 receptor activation in porcine left atrium.

Authors:  Sabine Weninger; Joris H De Maeyer; Romain A Lefebvre
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-03       Impact factor: 3.000

Review 5.  Prucalopride: A Review in Chronic Idiopathic Constipation.

Authors:  Karly P Garnock-Jones
Journal:  Drugs       Date:  2016-01       Impact factor: 9.546

Review 6.  Prucalopride: a review of its use in the management of chronic constipation.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

7.  5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.

Authors:  F Afzal; K W Andressen; H K Mørk; J M Aronsen; I Sjaastad; C P Dahl; T Skomedal; F O Levy; J-B Osnes; E Qvigstad
Journal:  Br J Pharmacol       Date:  2008-09-01       Impact factor: 8.739

8.  Ontogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT(4) receptors.

Authors:  Alejandro Galindo-Tovar; Maria Luisa Vargas; Elisa Escudero; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2009-01-19       Impact factor: 8.739

9.  Cardiac PDEs and crosstalk between cAMP and cGMP signalling pathways in the regulation of contractility.

Authors:  Finn Olav Levy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-05-07       Impact factor: 3.000

10.  Human 5-HT₄receptor stimulation in atria of transgenic mice.

Authors:  Ulrich Gergs; Anne Böckler; Henning Ebelt; Steffen Hauptmann; Nicolas Keller; Volker Otto; Klaus Pönicke; Wilhelm Schmitz; Joachim Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-01-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.